İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

SERKAN LEVENT

DOKTOR ÖĞRETİM ÜYESİ

ANADOLU ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ TEMEL ECZACILIK BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Eczacılıkta Analitik Kimya

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 132
  • Proje 0
  • Kitap 1
  • Bildiri 43
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 47 Q2 46 Q3 24 Q4 11
WoS (JCR) Q1 31 Q2 51 Q3 29 Q4 16
TR Index 2 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 26
Ort. yüzdelik 70.7%
Üst %1 payı 0.0%
Üst %10 payı 24.5%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 132 yayın

Scopus (SJR)
Q1 47 Q2 46 Q3 24 Q4 11
WoS (JCR)
Q1 31 Q2 51 Q3 29 Q4 16
TR Index
2 makale

Makale listesi

  1. 2026 Wound healing activity of Sweetgum oil (Liquidambar orientalis L. balsam): characterization of its mechanism of action on HaCaT human keratinocyte cells and possible responsible active constituents BMC Complementary Medicine and Therapies DOI 10.1186/s12906-025-05238-6 YÖKSİS SJR Q1 JCR Q1 OpenAlex 67.5%
  2. 2026 Design, synthesis and investigation of new imidazole derivatives with biological activities and antifungal effects Journal of Biomolecular Structure and Dynamics DOI 10.1080/07391102.2025.2490059 YÖKSİS SJR Q2 JCR Q3 OpenAlex 60.8%
  3. 2026 Box-bhenken Design Combined with 3D Surface Methodology for Optimization of an Eco-friendly HPLC Method to Determine Venetoclax in Human Plasma, and its Bioanalytical Method Validation According to ICH M10 Guideline Current Analytical Chemistry DOI 10.2174/0115734110352089241114112537 YÖKSİS SJR Q3 JCR Q4 OpenAlex 14.6%
  4. 2026 Design, synthesis, investigation, and biological activity assessments of n -allyl-2-(benzylidene) hydrazine-1-carbothioamide derivatives as monoamine oxidase-b inhibitor agents Zeitschrift für Naturforschung C DOI 10.1515/znc-2025-0107 YÖKSİS SJR Q3 JCR Q3 OpenAlex 24.4%
  5. 2026 Greenness, Whiteness, and Blueness Assessment With a Novel and Fully Validated HPLC Method for Simultaneous Analysis of Lumacaftor and Ivacaftor in Sweat International Journal of Analytical Chemistry DOI 10.1155/ianc/6649147 YÖKSİS SJR Q2 JCR Q3 OpenAlex 4.8%
  6. 2026 Determination of Flibanserin in Female Sexual Desire Enhancer Products by LC–MS/MS and Its Confirmation by LCMS-IT-TOF ACS Omega DOI 10.1021/acsomega.5c13004 YÖKSİS SJR Q1 JCR Q2 OpenAlex 9.5%
  7. 2026 COMPARISION OF BLACK AND GREEN TEA INFUSIONS: CATECHIN CONTENTS, ENZYME INHIBITIONS, ANTIOXIDANT AND ANTIBACTERIAL ACTIVITIES Ankara Universitesi Eczacilik Fakultesi Dergisi DOI 10.33483/jfpau.1624146 YÖKSİS SJR Q3 OpenAlex 3.7%
  8. 2025 Assessment of Inflammatory and Oxidative Stress Biomarkers for Predicting of Patients with Asymptomatic Carotid Artery Stenosis Journal of Clinical Medicine DOI 10.3390/jcm14030755 YÖKSİS SJR Q2 JCR Q1 OpenAlex 79.5%
  9. 2025 LC-MS/MS and LC-PDA Methods for Robust Determination of Glycerol Phenylbutyrate in Biological Fluids and High-Resolution Mass Spectrometric Identification of Forced Degradation Product and Its Whiteness ACS Omega DOI 10.1021/acsomega.5c00569 YÖKSİS SJR Q1 JCR Q2 OpenAlex 56.0%
  10. 2025 Greenness assessment and stability-indicating LC method for determination of alectinib using Box-Behnken design, high-resolution mass spectrometric identification, and molecular docking studies of its novel degradation products Microchemical Journal DOI 10.1016/j.microc.2025.113684 YÖKSİS SJR Q2 JCR Q1 OpenAlex 83.8%
  11. 2025 Synthesis of new piperazine‐oxadiazole derivatives and investigation of their anticancer activities Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.140298 YÖKSİS SJR Q2 JCR Q2 OpenAlex 69.7%
  12. 2025 Structure-based design, synthesis, and biological activity evaluation of chalcone-piperazine derivatives as dual AChE and MAO B inhibitors RSC Advances DOI 10.1039/D5RA05397H YÖKSİS SJR Q1 JCR Q2 OpenAlex 84.0%
  13. 2025 Design and Synthesis of Thiadiazole Derivatives as Dual EGFR/COX-2 Inhibitors with Anticancer and Anti-inflammatory Activities ACS Omega DOI 10.1021/acsomega.5c09752 YÖKSİS SJR Q1 JCR Q2 OpenAlex 86.1%
  14. 2025 Exploring SAR and Antifungal Activity of Pyrazole‐Thiazole‐Hydrazone Compounds Through Synthesis and Docking Studies Chemistry & Biodiversity DOI 10.1002/cbdv.202501313 YÖKSİS SJR Q2 JCR Q3 OpenAlex 80.7%
  15. 2025 A novel stability-indicating HPLC method for determining vorapaxar and conducting high-resolution mass spectroscopic characterization and molecular docking studies on its novel degradation product Microchemical Journal DOI 10.1016/j.microc.2025.113002 YÖKSİS SJR Q2 JCR Q1 OpenAlex 62.7%
  16. 2025 Latest developments in small molecule analgesics: heterocyclic scaffolds II Future Medicinal Chemistry DOI 10.1080/17568919.2025.2559570 YÖKSİS SJR Q3 JCR Q3 OpenAlex 81.1%
  17. 2025 Chemometrically assisted optimization and validation of the HPLC method for the analysis of alectinib and its related impurity with measurement uncertainty evaluation and whiteness, blueness, and greenness profile assessments BMC Chemistry DOI 10.1186/s13065-025-01509-y YÖKSİS SJR Q2 JCR Q2 OpenAlex 73.6%
  18. 2025 Multi-Target Quinoxaline Derivatives for Alzheimer’s Disease: Inhibitory Activities Against AChE and BACE-1 Enzymes Polycyclic Aromatic Compounds DOI 10.1080/10406638.2024.2442581 YÖKSİS SJR Q3 JCR Q2 OpenAlex 21.6%
  19. 2024 New Benzimidazole-Triazole Derivatives as Topoisomerase I Inhibitors: Design, Synthesis, Anticancer Screening, and Molecular Modeling Studies ACS Omega DOI 10.1021/acsomega.3c10345 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.1%
  20. 2024 Design, synthesis, and investigation of biological activities of new triazole derivatives with antifungal effect Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.138277 YÖKSİS SJR Q2 JCR Q2 OpenAlex 86.0%

Akademisyenlere dön